Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome
Mario Bazzan(Ospedale San Giovanni Bosco), Massimo Cugno(University of Milan), Silvana Tedeschi, Stefania Stella(University of Catania), Dario Roccatello(5T Torino (Italy)), Barbara Montaruli(A. O. Ordine Mauriziano di Torino), Simona Cardaropoli(University of Turin), Cristiana Marchese(A. O. Ordine Mauriziano di Torino), Gianluigi Ardissino(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Tullia Todros(Ospedale Sant'Anna)
Cited by 17
Related Papers
International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project
|The Lancet|2014|874
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism
|Nature Genetics|2022|613
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
|Clinical & Experimental Immunology|2014|239